QRT‐PCR analysis showed significantly lower expression of the genes: MAPK3 encoding ERK1 and MAPK1 encoding ERK2, p38, β‐catenin and E‐cadherin in prostate adenocarcinoma compared to BPH tissues (Figure 6). The gene discussed is MAPK14; the disease is benign prostatic hyperplasia.